The justices will decide whether to impose new restrictions on the abortion pill mifepristone and evaluate the conflict between federal law and state abortion bans.
The U.S. Supreme Court is poised to make a major decision in two pivotal abortion cases this month, marking the first significant review of abortion law since the 2022 ruling that overturned Roe v. Wade. The 2022 decision fundamentally altered abortion rights across the nation, triggering a wave of new state-level restrictions and intensifying efforts by anti-abortion groups to limit access to the procedure.
In the most closely watched case, the Court will decide whether to impose new limitations on the widely used abortion pill mifepristone, including potential restrictions on its availability by mail. The outcome could have broad implications on the accessibility of medication abortion, which has become a primary method for terminating pregnancies in many states.
Additionally, the justices will examine whether a federal law that mandates emergency room treatment conflicts with state abortion bans, particularly in cases where emergency care might involve abortion services. The decision will influence how abortion access is handled in medical emergencies and whether federal protections override state-level restrictions.
